Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia
- PMID: 18524776
- PMCID: PMC2494916
- DOI: 10.1074/jbc.M803510200
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia
Abstract
Non-alcoholic fatty liver disease is a serious health problem linked to obesity and type 2 diabetes. To investigate the biological outcome and therapeutic potential of hepatic fatty acid uptake inhibition, we utilized an adeno-associated virus-mediated RNA interference technique to knock down the expression of hepatic fatty acid transport protein 5 in vivo prior to or after establishing non-alcoholic fatty liver disease in mice. Using this approach, we demonstrate here the ability to achieve specific, non-toxic, and persistent knockdown of fatty acid transport protein 5 in mouse livers from a single adeno-associated virus injection, resulting in a marked reduction of hepatic dietary fatty acid uptake, reduced caloric uptake, and concomitant protection from diet-induced non-alcoholic fatty liver disease. Importantly, knockdown of fatty acid transport protein 5 was also able to reverse already established non-alcoholic fatty liver disease, resulting in significantly improved whole-body glucose homeostasis. Thus, continued activity of hepatic fatty acid transport protein 5 is required to sustain caloric uptake and fatty acid flux into the liver during high fat feeding and may present a novel avenue for the treatment of non-alcoholic fatty liver disease.
Figures
![FIGURE 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2494916/bin/zbc0340845590001.gif)
![FIGURE 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2494916/bin/zbc0340845590002.gif)
![FIGURE 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2494916/bin/zbc0340845590003.gif)
![FIGURE 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2494916/bin/zbc0340845590004.gif)
![FIGURE 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2494916/bin/zbc0340845590005.gif)
Similar articles
-
Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.Mol Metab. 2016 Aug 13;5(11):1072-1082. doi: 10.1016/j.molmet.2016.08.004. eCollection 2016 Nov. Mol Metab. 2016. PMID: 27818933 Free PMC article.
-
ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5).Lipids. 2011 Nov;46(11):991-1003. doi: 10.1007/s11745-011-3596-3. Epub 2011 Aug 9. Lipids. 2011. PMID: 21826528 Free PMC article.
-
Liver sympathetic denervation reverses obesity-induced hepatic steatosis.J Physiol. 2019 Sep;597(17):4565-4580. doi: 10.1113/JP277994. Epub 2019 Jul 26. J Physiol. 2019. PMID: 31278754 Free PMC article.
-
Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy.Am J Physiol Regul Integr Comp Physiol. 2015 Dec 15;309(12):R1569-77. doi: 10.1152/ajpregu.00385.2015. Epub 2015 Oct 21. Am J Physiol Regul Integr Comp Physiol. 2015. PMID: 26491104 Free PMC article.
-
The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.Semin Liver Dis. 2010 Nov;30(4):378-90. doi: 10.1055/s-0030-1267538. Epub 2010 Oct 19. Semin Liver Dis. 2010. PMID: 20960377 Review.
Cited by
-
Impact of Hydroxytyrosol-Rich Extract Supplementation in a High-Fat Diet on Gilthead Sea Bream (Sparus aurata) Lipid Metabolism.Antioxidants (Basel). 2024 Mar 27;13(4):403. doi: 10.3390/antiox13040403. Antioxidants (Basel). 2024. PMID: 38671851 Free PMC article.
-
Changes in Cells Associated with Insulin Resistance.Int J Mol Sci. 2024 Feb 18;25(4):2397. doi: 10.3390/ijms25042397. Int J Mol Sci. 2024. PMID: 38397072 Free PMC article. Review.
-
The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease-The Transition from an Adipocentric to Liver-Centric Approach.Curr Issues Mol Biol. 2023 Nov 14;45(11):9084-9102. doi: 10.3390/cimb45110570. Curr Issues Mol Biol. 2023. PMID: 37998747 Free PMC article. Review.
-
Hepatic Insulin Resistance Model in the Male Wistar Rat Using Exogenous Insulin Glargine Administration.Metabolites. 2023 Apr 18;13(4):572. doi: 10.3390/metabo13040572. Metabolites. 2023. PMID: 37110230 Free PMC article.
-
Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice.Nat Commun. 2023 Mar 14;14(1):1402. doi: 10.1038/s41467-023-37142-3. Nat Commun. 2023. PMID: 36918564 Free PMC article.
References
-
- Clark, J. M., Brancati, F. L., and Diehl, A. M. (2003) Am. J. Gastroenterol. 98 960-967 - PubMed
-
- Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., and Hobbs, H. H. (2004) Hepatology 40 1387-1395 - PubMed
-
- Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., and McGill, D. B. (1996) Hepatology 23 1464-1467 - PubMed
-
- Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., and Melchionda, N. (2001) Diabetes 50 1844-1850 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases